Mesalamine (Mesalamine W/Cleansing Wipes) Patent Expiration, LOE Window & CMS Spending

Mesalamine (Mesalamine W/Cleansing Wipes) by Padagis: Off-Patent Genericized (AB Competition), 0 AB generics, $1.7M 2024 CMS Part D & Medicaid spend, and 1 CA HCAI SB 17 wholesale price filings.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorPadagis
FDA Application & PathwayReconciled (UNLINKED)
Exclusivity / Cliff HorizonOff-Patent Genericized (AB Competition)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity DateNot listed / N/A
Orange Book Patents (*PED Extensions)0 patents (0 *PED)
Active AB-Rated Generic Competitors0
2024 CMS Total Public Spend$1.7M
2024 Medicare Part D Spend$1.4M
2024 Medicaid Spend$248K
Reported Wholesale Price Change (CA SB 17)1 WAC filings (max 36.1% 2-yr change)